The Macrophage: A Disputed Fortress in the Battle against Mycobacterium tuberculosis

CJ Queval, R Brosch, R Simeone - Frontiers in microbiology, 2017 - frontiersin.org
Mycobacterium tuberculosis (Mtb), the etiological agent of human tuberculosis (TB), has
plagued humans for thousands of years. TB still remains a major public health problem in …

Drug resistance in nontuberculous mycobacteria: mechanisms and models

S Saxena, HP Spaink, G Forn-Cuní - Biology, 2021 - mdpi.com
Simple Summary Recently, there has been a considerable rise in infections caused by
nontuberculous mycobacteria (NTM). These mycobacteria, which comprise a large and …

Recent developments of phosphodiesterase inhibitors: Clinical trials, emerging indications and novel molecules

AD Bondarev, MM Attwood, J Jonsson… - Frontiers in …, 2022 - frontiersin.org
The phosphodiesterase (PDE) enzymes, key regulator of the cyclic nucleotide signal
transduction system, are long-established as attractive therapeutic targets. During …

Perspective for precision medicine for tuberculosis

C Lange, R Aarnoutse, D Chesov… - Frontiers in …, 2020 - frontiersin.org
Tuberculosis is a bacterial infectious disease that is mainly transmitted from human to
human via infectious aerosols. Currently, tuberculosis is the leading cause of death by an …

Protection and pathology in TB: learning from the zebrafish model

AH Meijer - Seminars in immunopathology, 2016 - Springer
Zebrafish has earned its place among animal models of tuberculosis. Its natural pathogen,
Mycobacterium marinum, shares major virulence factors with the human pathogen …

Revolutionizing control strategies against Mycobacterium tuberculosis infection through selected targeting of lipid metabolism

H Kim, SJ Shin - Cellular and Molecular Life Sciences, 2023 - Springer
Lipid species play a critical role in the growth and virulence expression of Mycobacterium
tuberculosis (Mtb), the causative agent of tuberculosis (TB). During Mtb infection, foamy …

Repurposing tamoxifen as potential host-directed therapeutic for tuberculosis

R Boland, MT Heemskerk, G Forn-Cuní, CJ Korbee… - MBio, 2023 - Am Soc Microbiol
The global burden of tuberculosis (TB) is aggravated by the continuously increasing
emergence of drug resistance, highlighting the need for innovative therapeutic options. The …

[HTML][HTML] The antimicrobial activity of innate host-directed therapies–a systematic review

T Shapira, M Christofferson, Y Av-Gay - International Journal of …, 2024 - Elsevier
Intracellular human pathogens are the deadliest infectious diseases and pose great difficulty
to effectively treat due to their protection inside the host cell and the development of …

Tobacco smoke exposure recruits inflammatory airspace monocytes that establish permissive lung niches for Mycobacterium tuberculosis

B Corleis, CN Tzouanas, MH Wadsworth… - Science translational …, 2023 - science.org
Tobacco smoking doubles the risk of active tuberculosis (TB) and accounts for up to 20% of
all active TB cases globally. How smoking promotes lung microenvironments permissive to …

Host-directed therapy as a novel treatment strategy to overcome tuberculosis: targeting immune modulation

S Ahmed, R Raqib, GH Guðmundsson, P Bergman… - Antibiotics, 2020 - mdpi.com
Tuberculosis (TB) is one of the leading causes of mortality and morbidity, particularly in
developing countries, presenting a major threat to the public health. The currently …